Health Canada
A.L. 0904A
Ottawa
K1A 0K9
Canada
Tel: 613-957-2991
Fax: 613-941-5366
Website: http://www.hc-sc.gc.ca/
Email: info@www.hc-sc.gc.ca
1217 articles about Health Canada
-
Baxalta Announces Priority Review Status Granted By Health Canada For Irinotecan Liposome Injection (Nal-IRI) For New Drug Submission
1/7/2016
-
AbbVie's HUMIRA (Adalimumab) Receives First And Only Health Canada Approval For Moderate To Severe Hidradenitis Suppurativa
1/6/2016
-
Health Canada Issues Notice Of Compliance For Gilead’s Single Tabletregimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofoviralafenamide) For Treatment Of HIV-1 Infection
12/7/2015
-
Cipher Pharma Receives Health Canada Approval Of (Pr)Beteflam
12/7/2015
-
Boehringer Ingelheim And Eli Lilly Canada Inc. Release: Health Canada Approves JARDIANCE (empagliflozin) Tablets For Adults With Type 2 Diabetes
11/30/2015
-
ESSA Pharma Receives Health Canada Approval To Commence Clinical Development For EPI-506
11/5/2015
-
Anika Therapeutics Announces Health Canada Approval Of CINGAL For The Treatment Of Pain Associated With Osteoarthritis Of The Knee
11/3/2015
-
Cynosure Receives Health Canada Authorization To Market MonaLisa Touch For Genitourinary Syndrome Of Menopause
10/28/2015
-
Baxalta Gains Health Canada Approval For OBIZUR To Treat Patients With Acquired Hemophilia A
10/15/2015
-
Health Canada Initiates Review Of PTC Therapeutics' New Drug Submission For Translarna For The Treatment Of Duchenne Muscular Dystrophy
9/18/2015
-
Information Update - Health Canada Proposes Revised Labelling Standard For Non-Prescription Acetaminophen Products
9/16/2015
-
Health Canada Approves Amgen's New Cholesterol-Lowering Medication Repatha (evolocumab)
9/15/2015
-
BioMark Diagnostics Receives Clearance From Health Canada To Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay To Measure Response To Treatment For Lung Cancer
9/9/2015
-
Sandoz Canada Release: Health Canada Approves New Indications For Promnitrope (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)
9/3/2015
-
Relmada Therapeutics Receives Health Canada Clearance To Commence Multiple Ascending Dose Study With Promising NMDA Receptor Antagonist
8/17/2015
-
Alexion Pharma Canada Release: Health Canada Approves Strensiq (asfotase alfa), The First Therapy For Patients With Hypophosphatasia (HPP), An Ultra-Rare, Life-Threatening Disease
8/17/2015
-
Biogen Canada Inc. Release: Health Canada Approves PLEGRIDY (peginterferon beta-1a) For Adults With Relapsing Remitting Multiple Sclerosis
8/13/2015
-
Health Canada Approves he Glaukos iStent inject
8/10/2015
-
BTG plc Release: Health Canada Approves Varithena (Polidocanol Injectable Foam) For Patients With Varicose Veins
8/6/2015
-
Sorin Group S.p.A. Obtains Health Canada Approval for Perceval, Its Next Generation Sutureless Valve
8/5/2015